Evergreen Theragnostics Raises $26M, Boosting Radiopharma and CDMO Capabilities
Evergreen Theragnostics, US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today the successful completion of a $26M capital raise. This funding was supported by…